Consider Digestive Advantage® Daily Probiotic Supplement (Bacillus coagulans/Calcium) Capsules

By American Health Packaging

Does your facility order probiotics? Digestive Advantage® Daily Probiotic Supplement (Bacillus coagulans/calcium) Capsule is a new unit-dose offering from American Health Packaging. BC30 has been clinically studied and provides benefits for health care professionals to consider when advising their patients.
This document is intended for health care professionals. Health care professionals should use their own professional judgment when advising patients.

BC30 supports digestive and immune health*
When consumed daily, BC30 supported digestive health and was statistically significant in improving minor abdominal discomfort and bloating within a 2-week period.† BC30 has also been proven to support immune health.‡

BC30 survives 100x better§
BC30 is a unique and patented strain of probiotic with a protective, spore-like protein coating that allows it to withstand the harsh acidic environment of the stomach to reach the intestines. The benefits that have been clinically shown include:

• reducing minor abdominal discomfort and bloating*

• supporting key aspects of innate immune defense mechanisms*

In a study at an independent laboratory for survival in a simulated gastric environment, BC30 survived at least 100 times better compared to the leading probiotic product and leading yogurt products. The superior survivability enables BC30 to be temperature stable in formats which other probiotics may not be.

BC30 has a trusted safety profile*
BC30 is a transient colonizing probiotic, meaning it takes up only temporary residence in the intestines and prevents any unwanted potential for overgrowth of BC30 within the gastrointestinal tract. There have been extensive genomic and toxicological assessments.

If you have any questions, please contact

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

† Based on results of a randomized, double-blind, placebo-controlled trial where subjects received BC30 for 14 days. Statistically significant P<0.0003 for bloating vs. baseline (day 0).

‡ When taken once daily. Sources: Baron et al 2009. Postgraduate Medicine 2009; 121:71508e 1-5. Kimmel M et al. Methods Find Exp Clin Pharmacol 2010;32:129-132

§ Based on median survivability of Digestive Advantage probiotic vs. leading probiotic and yogurts in a simulated gastric environment.

© 2019 RB All rights reserved. REV. DIGFC072019

American Health Packaging makes no representation, warranties, or endorsement reading the quality, accuracy or reliability of any information (including this Product Sale Sheet), data, graphics, or other content of any kind posted or contained in this Digestive Advantage Product Sale Sheet.

Drug Distributor

American Health Packaging distribution facility has been awarded NABP accreditation.

Learn more